ArticleSurgical endoscopy2026
Development and validation of an interpretable predictive model for short-term rebleeding after endoscopic hemostasis in peptic ulcer: a retrospective single-center cohort study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effects of cisatracurium and rocuronium on intraoperative neuromonitoring and putuative mechanical trauma in 500 robotic baba thyroidectomies.Surgical endoscopy · 2026Article
- Robotic breast-conserving surgery: a retrospective study of feasibility and patient-reported aesthetic outcomes in 88 patients.Journal of robotic surgery · 2026Article
- Artificial Intelligence in Gastrointestinal Endoscopy and Hemostatic Decision-Making: Current Evidence, Clinical Implications and Implementation Barriers.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeptic ulcer bleeding (PUB) is a common, life-threatening disorder. Although endoscopic therapy achieves hemostasis, short-term rebleeding remains frequent, increasing mortality and healthcare burden. Existing tools lack accuracy and interpretability. This study aimed to develop and validate an interpretable machine learning (ML) model to predict rebleeding risk after initial therapy in PUB.
methodsWe retrospectively analyzed patients with Forrest Ia-IIb PUB undergoing emergency hemostasis at Shenzhen Hospital, Southern Medical University (June 2019-September 2023). Among 204 patients, 25 (12.25%) rebled. Nineteen clinical and laboratory features were collected, and 11 ML algorithms were evaluated. Data were split 7:3 into training and testing sets. Model performance was assessed by area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, F1 score, and Youden index. The best model was interpreted using SHapley Additive exPlanations (SHAP).
resultsCategorical boosting (CATBoost) achieved the best performance (AUC 0.980 training; 0.817 testing). Calibration confirmed stability. SHAP identified Rockall score, prothrombin time (PT), activated partial thromboplastin time (APTT), AIMS65 score, blood urea nitrogen (BUN), creatinine, and lesion location (particularly the descending duodenum) as the most important predictors. A web-based calculator was developed for individualized risk estimation.
conclusionWe established and validated an interpretable CATBoost model using routine variables to predict short-term rebleeding in PUB. This tool may aid early identification of high-risk patients and support individualized management strategies.
trial registrationThis study was registered at https://www.chictr.org.cn/ with the registration number ChiCTR2300079290.
Indexed as
Identifiers
41466141What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.